During the AD process, tau becomes hyperphosphorylated, undergoing proteolytic cleavage with resulting modifications such as O-glycosylation, sumoylation, ubiquitinylation, acetylation, and others [76]. The gene discussed is MAPT; the disease is Alzheimer disease.